HealthcareServices

Difficult-to-Express Proteins Global Forecast: Market to Scale Up to $8.98 Billion by 2030 at 11.6% CAGR

February 27, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the difficult-to-express proteins market from 2026–2035 with trusted insights from The Business Research Company

What is the estimated market size of the Difficult-to-Express Proteins Market by the end of 2030?

Significant growth has been observed in the difficult-to-express proteins market size over recent years. This market is projected to expand from $5.2 billion in 2025 to $5.79 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 11.3%. Historically, this growth has stemmed from several factors, including increased research into biologics, the inherent limitations of conventional expression systems, the broadening of academic protein research, rising demand for membrane proteins, and an increase in biotechnology funding.

The difficult-to-express proteins market is set for substantial expansion over the next few years. It is forecast to achieve a valuation of $8.99 billion by 2030, progressing at a compound annual growth rate (CAGR) of 11.6%. This anticipated growth during the forecast period is fueled by the expansion of protein therapeutics, breakthroughs in expression technologies, the increasing need for structural biology studies, a rise in pharmaceutical outsourcing, and the broadening scope of precision medicine research. Key trends expected in this period include a heightened demand for complex protein expression, the proliferation of cell-free protein synthesis, greater utilization of fusion and tag technologies, an expanding role in drug discovery applications, and the implementation of advanced expression systems.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12602&type=smp

What Drivers Are Shaping Future Opportunities In The Difficult-to-Express Proteins Market?

The future expansion of the difficult to express proteins market is anticipated to be fueled by the rising need for biopharmaceuticals. This driving force stems from the global increase in the adoption of biologics, therapeutic proteins, and innovative biopharmaceutical approaches for addressing various illnesses. The heightened demand is a result of a growing transition among patients and healthcare providers towards precision medicine and biologics, moving away from conventional small-molecule medications. The difficult to express proteins market plays a crucial role in supporting this trend by facilitating the production of intricate proteins—including multi-domain proteins, antibody fragments, fusion proteins, and post-translationally modified proteins—essential for these cutting-edge therapies. As an illustration, a report from Sartorius, a Germany-based international life science technology company, stated in July 2025 that biopharmaceutical drug sales climbed by approximately 9% to USD 458 billion in 2024, exceeding the previous year’s figures, and accounted for 41% of the overall pharmaceutical market, up from 40% in 2023. Consequently, the escalating demand for biopharmaceuticals is propelling the expansion of the difficult to express proteins market.

Which Segments Are Gaining Traction In The Difficult-to-Express Proteins Market?

The difficult-to-express proteins market covered in this report is segmented –

1) By Protein: Proteases, Kinases, Membrane Proteins, Other Proteins

2) By Expression Of Difficult Proteins: Disulfide-bonded Protein Expression, Membrane Protein Expression, Toxic Protein Expression, Target Protein Insolubility

3) By Technology: Cell-free Protein Synthesis, Prokaryotic Expression Systems, Small Ubiquitin-like Modifier (SUMO) Fusion System, Gene Fusion Systems, Other Technologies

4) By Application: Drug Discovery, Protein Purification, Protein Therapeutics, Disease Diagnostics And Monitoring, Other Applications

Subsegments:

1) By Proteases: Serine Proteases, Cysteine Proteases, Aspartic Proteases, Metalloproteases

2) By Kinases: Receptor Tyrosine Kinases, Serine Or Threonine Kinases, Cyclin-Dependent Kinases

3) By Membrane Proteins: G-Protein Coupled Receptors (GPCRs), Ion Channels, Transporters

4) By Other Proteins: Transcription Factors, Structural Proteins, Enzymes

What Industry Trends Are Transforming The Difficult-to-Express Proteins Market?

The development of innovative technologies is a key trend gaining popularity in the difficult-to-express protein market. Major companies operating in the difficult-to-express protein market are focused on developing inventive technologies to sustain their position in the market. For instance, in January 2023, Evozyne, a US-based biotechnology company, developed an innovative AI model called Protein Transformer Variational AutoEncoder to design therapeutic proteins. This technique creates a framework for effectively training and deploying large language models for biology. The resulting model is an innovative approach to deep learning that brings up new possibilities for the data-driven design of engineered proteins with specified functionality.

Who Are The Primary Competitors In The Global Difficult-to-Express Proteins Market?

Major companies operating in the difficult-to-express proteins market are Thermo Fisher Scientific Inc., Merck KGaA, Lonza Group Ltd, Catalent Inc., Sartorius AG, Charles River Laboratories International Inc., Bio-Rad Laboratories Inc., Samsung Biologics Co. Ltd., Bio-Techne Corp., GenScript Biotech Corporation, Ajinomoto Bio-Pharma Services, Novasep Holding SAS, Rentschler Biopharma SE, BioLegend Inc., Codexis Inc., Enzo Biochem Inc., Sino Biological Inc., Horizon Discovery Ltd., Creative Biolabs Inc., OriGene Technologies Inc., Celonic AG, Cube Biotech GmbH, Lucigen Corporation, Batavia Biosciences Inc., Cytovance Biologics Inc., Alloy Therapeutics Inc., Aragen Bioscience Inc., Selexis SA, LifeSensors Inc., Bionova Scientific Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/difficult-to-express-proteins-global-market-report

Which Global Regions Are Shaping The Competitive Landscape Of The Difficult-to-Express Proteins Market?

North America was the largest region in the difficult-to-express proteins market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the difficult-to-express proteins market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Difficult-to-Express Proteins Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12602&type=smp

Browse Through More Reports Similar to the Global Difficult-to-Express Proteins Market 2026, By The Business Research Company

Alternative Protein Market Report 2026

https://www.thebusinessresearchcompany.com/report/alternative-protein-global-market-report

Protein Engineering Market Report 2026

https://www.thebusinessresearchcompany.com/report/protein-engineering-global-market-report

Protein Expression Market Report 2026

https://www.thebusinessresearchcompany.com/report/protein-expression-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795